LPS itself has multiple adverse effects on the gut function, promoting intestinal inflammation and disrupting tight junctions (TJ) organization via specific signaling pathways which determines directly enterocytes shedding without compensatory TJ- releasing, and induces oxidative stress in epithelial cells, mitochondrial failure, and mitophagy [22]
It may set unrealistic expectations, leading people to believe they will see prescription-level weight loss or blood sugar control
so too has the nutraceutical industry started looking for alternatives to pharmaceutical-grade GLP-1 receptor agonists (Ozempic)
Another approach to reduce impact of anti-cancer chemotherapy on cardiac function is to explore cardioprotective effect of medication commonly used to treat cardiac disorders in non-cancer patients (e.g., ischemic heart disease, congestive heart failure etc.)
GLP-1 promotes mitochondrial metabolism in vascular smooth muscle cells by enhancing endoplasmic reticulum-mitochondria coupling
Retatrutide, being even more potent (see our complete analysis of Retatrutide weight loss results), likely falls in this range or higher without countermeasures